Mahsa Iravani

Genetically engineered dendritic cells in cancer immunotherapy: from immune reprogramming strategies to emerging CAR-DC platforms

Genetic engineering can enhance dendritic cell (DC) migration, antigen presentation, co-stimulation, cytokine production, survival, and resistance to tumor-mediated suppression. This review examines established engineering strategies and emerging chimeric antigen receptor-enginee...